Morningstar to acquire CRSP from University of Chicago for $375 million

Morningstar (NASDAQ:MORN) announced the acquisition of the Center for Research in Security Prices (CRSP) from the University of Chicago for $375 million, a strategic move set to significantly expand its index business. This deal will grant Morningstar control over CRSP Market Indexes, which currently benchmark over $3 trillion in US equities and are notably utilized by major funds such as Vanguard's. Expected to close in Q4 2025, the acquisition reinforces Morningstar's position as a leading global index provider by integrating CRSP's comprehensive historical data and established methodologies.

Analysis

Morningstar (MORN) is undertaking a significant strategic expansion of its index business through the acquisition of the Center for Research in Security Prices (CRSP) for $375 million. This transaction provides Morningstar with control over CRSP's market indexes, which serve as benchmarks for over $3 trillion in US equities and are utilized by major asset managers like Vanguard. The acquisition price represents a notable investment, acquiring an entity with approximately $55 million in annual revenue. This move is supported by Morningstar's strong financial health, as evidenced by a perfect Piotroski Score of 9, and its existing scale with $2.35 billion in annual revenue. The integration of CRSP's historical data and methodologies is poised to enhance Morningstar's competitive position, building on the momentum of its index division, which has been cited as the fastest-growing globally for the last five years. The deal's closure is projected for the fourth quarter of 2025, contingent upon customary regulatory approvals.

Key Decisions for Investors

• Investors should view this acquisition as a long-term positive catalyst that strengthens Morningstar's competitive moat in the high-margin index and data services industry.
• The company's strong fundamental health, indicated by a Piotroski Score of 9, suggests it is well-positioned to absorb the $375 million cost without materially stressing its balance sheet.
• Key items to monitor are the progress of regulatory approvals leading up to the expected Q4 2025 closing and the subsequent integration of CRSP's operations to realize anticipated revenue synergies.